Wordt geladen...
Interplay between Hepatitis C Virus and Redox Cell Signaling
Hepatitis C virus (HCV) infects approximately 3% of the world’s population. Currently licensed treatment of HCV chronic infection with pegylated-interferon-α and ribavirin, is not fully effective against all HCV genotypes and is associated to severe side effects. Thus, development of novel therapeut...
Bewaard in:
| Hoofdauteurs: | , , , , , |
|---|---|
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
Molecular Diversity Preservation International (MDPI)
2013
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3634496/ https://ncbi.nlm.nih.gov/pubmed/23443167 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/ijms14034705 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|